Company intelligence / Profile preview

南京优科生物医药集团

Nanjing, Jiangsu, Chinaes.commscope.com ↗

Ownership: Private
Development stage: Other

Overview

Nanjing Yoko Biopharmaceutical Group is an active, high-tech pharmaceutical company focused on innovative drug discovery and development. While specific clinical results are not publicly available, the company is recognized for its broad R&D pipeline, primarily in small molecules and potentially biologics, emphasizing proprietary intellectual property.

Modalities: Small moleculeBiologic
Industry: Biotech

Beyond the preview

Go deeper on 南京优科生物医药集团.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 南京优科生物医药集团.

Explore the full profile